Clinical Trial: A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies

U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07532746) titled 'A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies' on April 03.

Brief Summary: The main purpse of this study is to evaluate the safety and tolerability of KSD-101 in the treatment of relapsed or refractory EBV-associated hematological malignancies,to preliminarily explore the clinical efficacy ,evaluate the immune response to KSD-101 for the treatment in Patients with EBV-associated hematological diseases and the improvement in subjects' quality of life (QOL) after KSD-101 treatment.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Relapsed or Ref...